Nisa Investment Advisors
XERS icon

Nisa Investment Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Nisa Investment Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9K Buy
2,769
+565
+26% +$3.61K ﹤0.01% 2179
2026
Q1 		$12.8K Hold
2,204
– – ﹤0.01% 2151
2025
Q4 		$17.3K Hold
2,204
– – ﹤0.01% 1994
2025
Q3 		$17.9K Hold
2,204
– – ﹤0.01% 2049
2025
Q2 		$10.3K Buy
2,204
+1,485
+207% +$6.8K ﹤0.01% 2249
2025
Q1 		$3.95K Hold
719
– – ﹤0.01% 2305
2024
Q4 		$2.44K Hold
719
– – ﹤0.01% 2432
2024
Q3 		$2.05K Buy
719
+340
+90% +$873 ﹤0.01% 2390
2024
Q2 		$853 Buy
+379
New +$764 ﹤0.01% 2552
2023
Q1 		– Sell
-30
Closed – – 2736
2022
Q4 		$0 Buy
+30
New +$42 ﹤0.01% 2745

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nisa Investment Advisors's XERS Position: Q2 2026 in Review

Nisa Investment Advisors increased its Xeris Biopharma Holdings (XERS) stake by 26% in Q2 2026, buying an estimated $3.61K and bringing the position to 2,769 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Nisa Investment Advisors first reported a position in XERS in Q4 2022 and has held it in 10 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Nisa Investment Advisors held 2,769 shares of Xeris Biopharma Holdings worth $21.9K as of Q2 2026.
  • Nisa Investment Advisors bought 565 Xeris Biopharma Holdings shares in Q2 2026, an estimated $3.61K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2179 holding.
  • Nisa Investment Advisors first reported a position in Xeris Biopharma Holdings in Q4 2022 and has held it in 10 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.